Ishemgulova A, Mukhamedova L, Trebichalska Z, Rajecka V, Payne P, Smerdova L
Commun Biol. 2024; 7(1):1465.
PMID: 39511383
PMC: 11543853.
DOI: 10.1038/s42003-024-07147-9.
Real-Hohn A, Groznica M, Loffler N, Blaas D, Kowalski H
Front Microbiol. 2020; 11:1442.
PMID: 32676065
PMC: 7333345.
DOI: 10.3389/fmicb.2020.01442.
Ruokolainen V, Domanska A, Laajala M, Pelliccia M, Butcher S, Marjomaki V
J Virol. 2019; 93(17).
PMID: 31189702
PMC: 6694817.
DOI: 10.1128/JVI.00599-19.
Kumar M, Blaas D
J Virol. 2013; 87(20):11309-12.
PMID: 23946453
PMC: 3807301.
DOI: 10.1128/JVI.02055-13.
Harutyunyan S, Kumar M, Sedivy A, Subirats X, Kowalski H, Kohler G
PLoS Pathog. 2013; 9(4):e1003270.
PMID: 23592991
PMC: 3617019.
DOI: 10.1371/journal.ppat.1003270.
Insights into minor group rhinovirus uncoating: the X-ray structure of the HRV2 empty capsid.
Garriga D, Pickl-Herk A, Luque D, Wruss J, Caston J, Blaas D
PLoS Pathog. 2012; 8(1):e1002473.
PMID: 22241997
PMC: 3252380.
DOI: 10.1371/journal.ppat.1002473.
Liposomal nanocontainers as models for viral infection: monitoring viral genomic RNA transfer through lipid membranes.
Bilek G, Matscheko N, Pickl-Herk A, Weiss V, Subirats X, Kenndler E
J Virol. 2011; 85(16):8368-75.
PMID: 21680510
PMC: 3147984.
DOI: 10.1128/JVI.00329-11.
Picornaviruses.
Tuthill T, Groppelli E, Hogle J, Rowlands D
Curr Top Microbiol Immunol. 2010; 343:43-89.
PMID: 20397067
PMC: 3018333.
DOI: 10.1007/82_2010_37.
Low pH-triggered beta-propeller switch of the low-density lipoprotein receptor assists rhinovirus infection.
Konecsni T, Berka U, Pickl-Herk A, Bilek G, Khan A, Gajdzig L
J Virol. 2009; 83(21):10922-30.
PMID: 19706701
PMC: 2772763.
DOI: 10.1128/JVI.01312-09.
A positive-feedback mechanism promotes reovirus particle conversion to the intermediate associated with membrane penetration.
Agosto M, Myers K, Ivanovic T, Nibert M
Proc Natl Acad Sci U S A. 2008; 105(30):10571-6.
PMID: 18653761
PMC: 2492467.
DOI: 10.1073/pnas.0802039105.
Thermostabilizing mutations in reovirus outer-capsid protein mu1 selected by heat inactivation of infectious subvirion particles.
Middleton J, Agosto M, Severson T, Yin J, Nibert M
Virology. 2007; 361(2):412-25.
PMID: 17208266
PMC: 1913285.
DOI: 10.1016/j.virol.2006.11.024.
Nonneutralizing human rhinovirus serotype 2-specific monoclonal antibody 2G2 attaches to the region that undergoes the most dramatic changes upon release of the viral RNA.
Hewat E, Blaas D
J Virol. 2006; 80(24):12398-401.
PMID: 17005641
PMC: 1676314.
DOI: 10.1128/JVI.01399-06.
Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis.
Brabec M, Schober D, Wagner E, Bayer N, Murphy R, Blaas D
J Virol. 2004; 79(2):1008-16.
PMID: 15613329
PMC: 538566.
DOI: 10.1128/JVI.79.2.1008-1016.2005.
Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH.
Brabec M, Baravalle G, Blaas D, Fuchs R
J Virol. 2003; 77(9):5370-7.
PMID: 12692239
PMC: 153956.
DOI: 10.1128/jvi.77.9.5370-5377.2003.
Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.
McCright I, Tsunoda I, Libbey J, Fujinami R
J Neurovirol. 2002; 8(2):100-10.
PMID: 11935462
DOI: 10.1080/13550280290049561.
The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry.
Basavappa R, Hogle J
J Virol. 1998; 72(9):7551-6.
PMID: 9696852
PMC: 109999.
DOI: 10.1128/JVI.72.9.7551-7556.1998.
Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.
Schober D, Kronenberger P, Prchla E, Blaas D, Fuchs R
J Virol. 1998; 72(2):1354-64.
PMID: 9445036
PMC: 124614.
DOI: 10.1128/JVI.72.2.1354-1364.1998.
The poliovirus 135S particle is infectious.
Curry S, Chow M, Hogle J
J Virol. 1996; 70(10):7125-31.
PMID: 8794359
PMC: 190765.
DOI: 10.1128/JVI.70.10.7125-7131.1996.
Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating.
Couderc T, Delpeyroux F, Le Blay H, Blondel B
J Virol. 1996; 70(1):305-12.
PMID: 8523541
PMC: 189818.
DOI: 10.1128/JVI.70.1.305-312.1996.
Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
Couderc T, HOGLE J, Le Blay H, Horaud F, Blondel B
J Virol. 1993; 67(7):3808-17.
PMID: 8389907
PMC: 237745.
DOI: 10.1128/JVI.67.7.3808-3817.1993.